source
- Kyverna Therapeutics aims to file first CAR-T cell therapy for autoimmune diseaseKyverna Therapeutics is preparing what could become the first regulatory filing for a CAR-T cell therapy targeting an autoimmune condition. The company has been developing its miv-cel construct in…
- Australia's TGA opens consultation to revamp rules for digital mental health toolsThe Therapeutic Goods Administration (TGA) has launched a public consultation aimed at updating the regulatory framework that governs digital mental health tools in Australia. The move seeks to cla…